--------------------------------------------------------------------------------------------------------------------------------------------

QPA's cascaded in 2024

QPA REVISED TEMPLATE JANUARY 2024

QPA 2024-22 Safe use of Valproate medicines - Pathways and Intranet page

*Amended* QPA 2024-21 Identification of service users prescribed Clozapine on MAST using Rio Clozapine Alert v2

QPA 2024-21 Identification of service users prescribed Clozapine on MAST using Rio Clozapine Alert

QPA 2024-20 Single Patient Use Medication Injectable Pen Devices (Update to previousQPA 2024-21 Identification of service users prescribed Clozapine on MAST using Rio Clozapine Alert QPA 2019-36)

QPA 2024-19 Utilisation of Lone Working Device

QPA 2024-18 What to do if service users are unable to engage in decisions about care & treatment of physical conditions or unwilling to engage

QPA 2024-17 Monitoring of patients prescribed lithium

QPA 2024-16 Prescribing Trust owned Nebulisers from Community Equipment Stores

QPA 2024-15 Choking Incidents: (i) Response to mild and severe obstruction (ii) Incident coding when submitting incident reports

QPA 2024-14 Insulin Cartridges and Pen Devices

QPA 2024-13 Correct Use Of Different Sodium Chloride 0.9% Solution Formulations V1.3

QPA 2024-12 New method of smuggling illicit substances onto a ward environment

QPA 2024-11 Safer Use Of High Dose Antipsychotic Treatment

QPA 2024-10 Signing in and out of buildings

QPA 2024-09 Safe Management and Storage of Controlled Drugs in Care Homes

QPA 2024-08 Reporting the death of a person with a learning disability or autism

QPA 2024-07 Safe Use of Valproate Update

QPA 2024-06 Nursing Reviews of Secluded Patients

QPA 2024-05 Oxygen Management within Walk in Centres/ Urgent Care Treatment centres and Children’s Special Schools Community Care Division

QPA 2024-04 Safe Medicines Administration v.2

QPA 2024-03 Electric shocks from unreported broken/damaged electrical appliances

QPA 2024-02 Escalation of Serious Controlled Drug Incidents

QPA 2024-01 Autism and Suicide

 

--------------------------------------------------------------------------------------------------------------------------------------------

QPA's cascaded in 2023

QPA 2023-66 Update on unified Do Not Attempt Cardio-Pulmonary Resuscitation (uDNACPR)

QPA 2023-65 Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products

*Amended* QPA 2023-64 v2 Use of Emergency Medication Cabinets to access medication in an emergency when the pharmacy department is closed

QPA 2023-64 Use of Emergency Medication Cabinets to access medication in an emergency when the pharmacy department is closed

QPA 2023- 62 Escalation process for service disruption & other incidents of concern

*Amended* QPA 2023- 61 Correct Assembly and Disposal of Clinical Waste

QPA 2023-61 Correct Assembly and Disposal of Clinical Waste

QPA 2023-60 Prescribing as a Non-Medical Prescriber

QPA 2023-59 Care of Percutaneous Endoscopic Gastrostomy (PEG) tube

QPA 2023-58 Good Practice Prescribing ot Antimicrobials

QPA 2023-57 Concealed Blades in a Key Ring and a Vape 

*Amended* QPA 2023-57 Concealed Blades in a Key Ring and a Vape

QPA 2023-56 Removal of kitchen appliance within non designated areas

*Amended* QPA 2023-55 Prohibited item – Plastic Bags

QPA 2023-55 Prohibited item – Plastic Bags

QPA 2023-54 Cardiac Chest Pain

QPA 2023-53 -Revised - GlucoRx HCT External Quality Assurance

QPA 2023-52 Safety risk with patient access to wooden cutlery

QPA 2023-51 Recording of all contacts/discussions that take place with service users’ carer/family.

QPA 2023-50 Contraindications of use of inadine and all forms of cadexomer iodine and povidone-iodine

QPA 2023-49 Patient identification – medicines administration

QPA 2023-48 v0.2 Duty of Candour updated Policy

QPA 2023-47 Ingestion of fruit stones and potential for Cyanide toxicity v.2

QPA 2023-46 Disposal of out-of-date COVID-19 tests and PPE

QPA 2023-45 Responsibility to Identify Carers and Refer for Carer’s Assessment

*Amended* QPA 2023-44 Subcutaneous prescribing and administration of medication for pain relief in the last days of life v2

QPA 2023-44 Subcutaneous prescribing and administration of medication for pain relief in the last days of life

*Amended* QPA 2023-43 Security of Controlled Drugs Keys v.2

QPA 2023-43 Security of Controlled Drugs Keys

QPA 2023-42 Prescribing on paper records for wards that have ePMA

QPA 2023-41 Use of Mattress Bags

QPA 2023-40 Potent synthetic opioids implicated in heroin overdoses and deaths.

QPA 2023-39 New Trust Wide MMP24 Safe Use of Clozapine Procedure

QPA 2023-38 Dealing with Temperature Excursions

QPA 2023-37 Incident reporting: Identification of the appropriate level of harm

QPA 2023-36 Quetiapine Modified Release (MR) – Good practice prescribing principles

QPA 2023-35 Discharge Planning from Inpatient Mental Health Wards

QPA 2023-34 High Risk Ligature Incidents in In-patients: Recording and Review of Risk Alerts within the Rio Clinical Record.

QPA 2023-33 to Charging of Electric Vehicles

*Amended* QPA 2023-32 Aripiprazole and impulsive behaviours

QPA 2023-31 GlucoRx HCT External Quality Assurance

QPA 2023-30 Melatonin – Good practice prescribing principles

QPA 2023-29 QPA to Supporting people who may present with behaviours of concern

QPA 2023-28 v3 to promote Risk Assessment regarding the use of Sharps within the Community of Inoculation Injuries (formerly ‘Needle stick and Sharps’).

QPA 2023-27 Internal Transfer of Care; Inpatient Medication Records & Clinical Notes

QPA 2023-26 Security Alert - Knives disguised as pens

QPA 2023-25 Equipment update - Introduction of an Adult Bag Valve Mask (BVM) with a pre connected Heat Moisture Exchange (HME) filter

QPA 2023-24 Good Practice Prescribing of Antimicrobials

*Amended* QPA 2023-23 Urgent Class 1 Recall of Emerade Auto-injector v.2

QPA 2023-23 Urgent Class 1 Recall of Emerade Auto-injector

QPA 2023-22 Administration of antipsychotic long acting injections and depot injections in the acute hospital setting

QPA 2023-21 Libre Flash blood Glucose monitoring

QPA 2023-20 Key testing for key operated fire alarm call point and emergency override door switches

QPA 2023-19 Removal of the build up of lint in tumble dryers to prevent fire

Quality Practice Alerts Template revised January 2023

QPA 2023-18 Wearing of a lap strap in a wheelchair

QPA 2023-17 Raising awareness of sodium nitrite as a potential means of suicide

QPA 2023-16 Patient identification

QPA 2023-15 Clonazepam added to restricted drug list

QPA 2023-14 Reporting of Needle Stick and other blood borne/body fluid injuries to Occupational Health via the new Trust reporting system - Empactis

QPA 2023-13 Switch to a New Formulation of Paliperidone Palmitate Long-Acting Injection

QPA 2023-12 Identifying and Reporting of infrequently Used water outlets

QPA 2023-11 Choking Risks Trust Wide

QPA 2023-10 Importance of obtaining relevant contact details and informing, involving ‘significant other’ in patient care.

QPA 2023-09 Identification and management of Diabetic Ketoacidosis

QPA 2023-08 Nursing Reviews of Secluded Patients – Code of Practice (CoP)

QPA 2023-07 Reporting injuries to patients under Reporting of Injuries, Diseases and Dangerous Occurrences Regulations (RIDDOR)

QPA 2023-06 Inadvertent Oral Administration of Potassium Permanganate

QPA 2023-05 Accurate completion of food and fluid charts during in patient admission

QPA 2023-04 Safeguarding Response to Patient on Patient assaults v.2

QPA 2023-03 Ligature risk alert - Ceiling Vents

QPA 2023-02 Correct process to check and re-inflate the balloon on a balloon retained gastrostomy tube

QPA 2023-01 Safe prescribing of medication

 

--------------------------------------------------------------------------------------------------------------------------------------------

QPA's cascaded in 2022

Quality Practice Alerts - All Items (merseycare.nhs.uk)

until QPAs are fully uploaded please see link below (all QPAs are currenlty on share point)

QPA Template Revised on 08.08.22

QPA 2022-66: Staff who sustain a head injury V2

QPA 2022-65: Safe and Therapeutic Leave (v2)

QPA 2022-51: Novo Rapid Insulin 100 units in 1ml and Saxenda Liraglutide 6mg in 1ml pre filled pen

QPA 2022-44: Reminder of staff responsibilities relating to Controlled Drug Activities

QPA 2022-43: Carrying out and Recording Supportive Observations in Secure and SpLD Division

 

--------------------------------------------------------------------------------------------------------------------------------------------

QPA's cascaded in 2019

QPA 2019-30 Administration of Medication